Dorian, I agree and when you consider Big Pharma has publicly admitted it is hunting for patent rich companies. Biosante's extensive patent portfolio is not even considered in the equation.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.